SCHEMBL5469717

SCHEMBL5469717

N#Cc1cccc(COc2ccccc2Cl)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 6/20 0.74
HPGD P15428 3/20 0.56
MEN1 O00255 2/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
KMT2A Q03164 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MITF O75030 1/20 0.56
TP53 P04637 1/20 0.56
XBP1 P17861 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
SLC6A4 P31645 2/20 0.53
HTR6 P50406 2/20 0.51
MAPT P10636 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
PDCD1 Q15116 2/20 0.48
CD274 Q9NZQ7 2/20 0.48
SGMS2 Q8NHU3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22480929 0.90 MRGPRX4 (0.68) MRGPRX4HPGDMEN1NPC1RAB9A
SCHEMBL22480554 0.85 MRGPRX4 (1.00) MRGPRX4HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL22469778 0.83 MRGPRX4 (0.76) MRGPRX4SLC6A4HTR6PDCD1CD274
SCHEMBL31568445 0.83 MRGPRX4 (0.76) MRGPRX4SLC6A4HTR6PDCD1CD274
SCHEMBL14854689 0.83 MRGPRX4 (0.76) MRGPRX4SLC6A4HTR6PDCD1CD274
SCHEMBL28102426 0.83 MRGPRX4 (0.67) MRGPRX4SLC6A4HTR6PDCD1CD274
SCHEMBL22469722 0.80 MRGPRX4 (1.00) MRGPRX4
SCHEMBL31568423 0.80 MRGPRX4 (1.00) MRGPRX4
SCHEMBL9975339 0.80 MRGPRX4 (0.70) MRGPRX4SLC6A4HTR6MAPTPDCD1
SCHEMBL3949409 0.80 MRGPRX4 (0.50) MRGPRX4HPGDMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 MRGPRX4 589/4885HPGD 2446/4885MEN1 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.